Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Jochen Harbott
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Living Beings
Anatomy
Procedures
Chemicals & Drugs
Concepts & Ideas
Physiology
Sign-in to see full Profile
Network (preview)
36
Ludwig, Wolf-Dieter
34
Schrappe, Martin
33
Lampert, Fritz
32
Borkhardt, Arndt
18
Haas, Oskar
17
Riehm, Hansjörg
17
Reiter, Alfred
17
Viehmann, Susanne
16
Repp, Roland
14
Zimmermann, Martin
12
Stanulla, Martin
11
Bartram, Claus
9
Creutzig, Ursula
9
Gadner, Helmut
9
Janka-Schaub, Gritta
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Jochen Harbott (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: von Goessel H; Jacobs U; Semper S; Krumbholz M; Langer T; Keller T; Schrauder A; van der Velden V H J; van Dongen J J M; Harbott J; Panzer-Grümayer E R; Schrappe M; Rascher W; Metzler M
Cluster analysis of genomic ETV6-RUNX1 (TEL-AML1) fusion sites in childhood acute lymphoblastic leukemia.
Leukemia research 2009;33(8):1082-8.
-
2009: Kawamata Norihiko; Ogawa Seishi; Seeger Karl; Kirschner-Schwabe Renate; Huynh Thien; Chen John; Megrabian Nairi; Harbott Jochen; Zimmermann Martin; Henze Günter; Schrappe Martin; Bartram Claus R; Koeffler H Phillip
Molecular allelokaryotyping of relapsed pediatric acute lymphoblastic leukemia.
International journal of oncology 2009;34(6):1603-12.
-
2009: Adler Ronald; Viehmann Susanne; Kuhlisch Eberhard; Martiniak Yvonne; Röttgers Silja; Harbott Jochen; Suttorp Meinolf
Correlation of BCR/ABL transcript variants with patients' characteristics in childhood chronic myeloid leukaemia.
European journal of haematology 2009;82(2):112-8.
-
2008: Kawamata Norihiko; Ogawa Seishi; Zimmermann Martin; Niebuhr Birte; Stocking Carol; Sanada Masashi; Hemminki Kari; Yamatomo Go; Nannya Yasuhito; Koehler Rolf; Flohr Thomas; Miller Carl W; Harbott Jochen; Ludwig Wolf-Dieter; Stanulla Martin; Schrappe Martin; Bartram Claus R; Koeffler H Phillip
Cloning of genes involved in chromosomal translocations by high-resolution single nucleotide polymorphism genomic microarray.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(33):11921-6.
-
2008: le Viseur Christoph; Hotfilder Marc; Bomken Simon; Wilson Kerrie; Röttgers Silja; Schrauder André; Rosemann Annegret; Irving Julie; Stam Ronald W; Shultz Leonard D; Harbott Jochen; Jürgens Heribert; Schrappe Martin; Pieters Rob; Vormoor Josef
In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties.
Cancer cell 2008;14(1):47-58.
-
2008: Attarbaschi Andishe; Mann Georg; Panzer-Grümayer Renate; Röttgers Silja; Steiner Manuel; König Margit; Csinady Eva; Dworzak Michael N; Seidel Markus; Janousek Dasa; Möricke Anja; Reichelt Carsten; Harbott Jochen; Schrappe Martin; Gadner Helmut; Haas Oskar A
Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(18):3046-50.
-
2008: Steinemann Doris; Cario Gunnar; Stanulla Martin; Karawajew Leonid; Tauscher Marcel; Weigmann Anja; Göhring Gudrun; Ludwig Wolf-Dieter; Harbott Jochen; Radlwimmer Bernhard; Bartram Claus; Lichter Peter; Schrappe Martin; Schlegelberger Brigitte
Copy number alterations in childhood acute lymphoblastic leukemia and their association with minimal residual disease.
Genes, chromosomes & cancer 2008;47(6):471-80.
-
2008: Möricke Anja; Reiter Alfred; Zimmermann Martin; Gadner Helmut; Stanulla Martin; Dördelmann Michael; Löning Lutz; Beier Rita; Ludwig Wolf-Dieter; Ratei Richard; Harbott Jochen; Boos Joachim; Mann Georg; Niggli Felix; Feldges Andreas; Henze Günter; Welte Karl; Beck Jörn-Dirk; Klingebiel Thomas; Niemeyer Charlotte; Zintl Felix; Bode Udo; Urban Christian; Wehinger Helmut; Niethammer Dietrich; Riehm Hansjörg; Schrappe Martin;
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.
Blood 2008;111(9):4477-89.
-
2008: Hauer Julia; Tosi Sabrina; Schuster Friedhelm R; Harbott Jochen; Kolb Hans-Jochem; Borkhardt Arndt
Graft versus leukemia effect after haploidentical HSCT in a MLL-negative infant AML with HLXB9/ETV6 rearrangement.
Pediatric blood & cancer 2008;50(4):921-3.
-
2008: Strehl Sabine; Nebral Karin; König Margit; Harbott Jochen; Strobl Herbert; Ratei Richard; Struski Stephanie; Bielorai Bella; Lessard Michel; Zimmermann Martin; Haas Oskar A; Izraeli Shai
ETV6-NCOA2: a novel fusion gene in acute leukemia associated with coexpression of T-lymphoid and myeloid markers and frequent NOTCH1 mutations.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(4):977-83.
-
2008: Starý Jan; Baumann Irith; Creutzig Ursula; Harbott Jochen; Michalova Kyra; Niemeyer Charlotte
Getting the numbers straight in pediatric MDS: distribution of subtypes after exclusion of down syndrome.
Pediatric blood & cancer 2008;50(2):435-6.
-
2008: Kawamata Norihiko; Ogawa Seishi; Zimmermann Martin; Kato Motohiro; Sanada Masashi; Hemminki Kari; Yamatomo Go; Nannya Yasuhito; Koehler Rolf; Flohr Thomas; Miller Carl W; Harbott Jochen; Ludwig Wolf-Dieter; Stanulla Martin; Schrappe Martin; Bartram Claus R; Koeffler H Phillip
Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray.
Blood 2008;111(2):776-84.
-
2007: Troeger Anja; Gudowius Sonja; Escherich Gabriele; den Boer Monique L; Glouchkova Ludmila; Ackermann Birgit; Meisel Roland; Laws Hans-Juergen; Groeger Marketa; Wessalowski Ruediger; Willers Reinhart; Harbott Jochen; Pieters Rob; Goebel Ulrich; Janka-Schaub Gritta E; Hanenberg Helmut; Dilloo Dagmar
High nerve growth factor receptor (p75NTR) expression is a favourable prognostic factor in paediatric B cell precursor-acute lymphoblastic leukaemia.
British journal of haematology 2007;139(3):450-7.
-
2007: Busch K; Keller T; Fuchs U; Yeh R-F; Harbott J; Klose I; Wiemels J; Novosel A; Reiter A; Borkhardt A
Identification of two distinct MYC breakpoint clusters and their association with various IGH breakpoint regions in the t(8;14) translocations in sporadic Burkitt-lymphoma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(8):1739-51.
-
2007: Damm-Welk Christine; Busch Kerstin; Burkhardt Birgit; Schieferstein Jutta; Viehmann Susanne; Oschlies Ilske; Klapper Wolfram; Zimmermann Martin; Harbott Jochen; Reiter Alfred; Woessmann Willi
Prognostic significance of circulating tumor cells in bone marrow or peripheral blood as detected by qualitative and quantitative PCR in pediatric NPM-ALK-positive anaplastic large-cell lymphoma.
Blood 2007;110(2):670-7.
-
2007: Haferlach Claudia; Rieder Harald; Lillington Debra M; Dastugue Nicole; Hagemeijer Anne; Harbott Jochen; Stilgenbauer Stephan; Knuutila Sakari; Johansson Bertil; Fonatsch Christa
Proposals for standardized protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes.
Genes, chromosomes & cancer 2007;46(5):494-9.
-
2007: Metzler Markus; Bruch Jochen; Stachel Daniel; Langer Thorsten; Borkhardt Arndt; Harbott Jochen; Rascher Wolfgang; Holter Wolfgang
Temporary blast reduction after immunoglobulin administration for congenital cytomegalovirus infection masking infant leukemia with cryptic MLL rearrangement.
Leukemia research 2007;31(4):553-7.
-
2006: Strehl Sabine; König Margit; Meyer Claus; Schneider Björn; Harbott Jochen; Jäger Ulrich; von Bergh Anne R M; Loncarevic Ivan F; Jarosova Marie; Schmidt Helmut H; Moore Steven D P; Marschalek Rolf; Haas Oskar A
Molecular dissection of t(11;17) in acute myeloid leukemia reveals a variety of gene fusions with heterogeneous fusion transcripts and multiple splice variants.
Genes, chromosomes & cancer 2006;45(11):1041-9.
-
2006: Burkhardt B; Bruch J; Zimmermann M; Strauch K; Parwaresch R; Ludwig W-D; Harder L; Schlegelberger B; Mueller F; Harbott J; Reiter A
Loss of heterozygosity on chromosome 6q14-q24 is associated with poor outcome in children and adolescents with T-cell lymphoblastic lymphoma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(8):1422-9.
-
2006: Neudenberger J; Hotfilder M; Rosemann A; Langebrake C; Reinhardt D; Pieters R; Schrauder A; Schrappe M; Röttgers S; Harbott J; Vormoor J
Lack of expression of the chondroitin sulphate proteoglycan neuron-glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11).
British journal of haematology 2006;133(3):337-44.
-
2006: Lauten M; Schrauder A; Kardinal C; Harbott J; Welte K; Schlegelberger B; Schrappe M; von Neuhoff N
Unsupervised proteome analysis of human leukaemia cells identifies the Valosin-containing protein as a putative marker for glucocorticoid resistance.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(5):820-6.
-
2005: Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig W-D; Riehm H; Schrappe M
Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
Klinische Pädiatrie 2005;217(6):310-20.
-
2005: Panzer-Grümayer E Renate; Cazzaniga Giovanni; van der Velden Vincent H J; del Giudice Laura; Peham Martina; Mann Georg; Eckert Conny; Schrauder Andre; Germano Giuseppe; Harbott Jochen; Basso Giuseppe; Biondi Andrea; van Dongen Jacques J M; Gadner Helmut; Haas Oskar A
Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(21):7720-7.
-
2005: Tosi Sabrina; Ballabio Erica; Teigler-Schlegel Andrea; Boultwood Jackie; Bruch Jochen; Harbott Jochen
Characterization of 6q abnormalities in childhood acute myeloid leukemia and identification of a novel t(6;11)(q24.1;p15.5) resulting in a NUP98-C6orf80 fusion in a case of acute megakaryoblastic leukemia.
Genes, chromosomes & cancer 2005;44(3):225-32.
-
2005: Reinhardt D; Diekamp S; Langebrake C; Ritter J; Stary J; Dworzak M; Schrauder A; Zimmermann M; Fleischhack G; Ludwig W-D; Harbott J; Creutzig U
Acute megakaryoblastic leukemia in children and adolescents, excluding Down's syndrome: improved outcome with intensified induction treatment.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(8):1495-6.
-
2005: Schuster F R; Führer M; Woessmann W; Reiter A; Harbott J; Viehmann S; Borkhardt A
Treatment of relapsed acute myelogeneous leukaemia with MLL/AF 6 fusion after stem cell transplantation by intensive reinduction followed by adoptive immunotherapy.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(7):1273-4; author reply 1275-6.
-
2005: Moorman A V; Raimondi S C; Pui C H; Baruchel A; Biondi A; Carroll A J; Forestier E; Gaynon P S; Harbott J; Harms D O; Heerema N; Pieters R; Schrappe M; Silverman L B; Vilmer E; Harrison C J;
No prognostic effect of additional chromosomal abnormalities in children with acute lymphoblastic leukemia and 11q23 abnormalities.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(4):557-63.
-
2005: Hotfilder Marc; Röttgers Silja; Rosemann Annegret; Schrauder André; Schrappe Martin; Pieters Rob; Jürgens Heribert; Harbott Jochen; Vormoor Josef
Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells.
Cancer research 2005;65(4):1442-9.
-
2004: Kracht Thorben; Schrappe Martin; Strehl Sabine; Reiter Alfred; Elsner Holger-Andreas; Trka Jan; Cario Gunnar; Viehmann Susanne; Harbott Jochen; Borkhardt Arndt; Metzler Markus; Langer Thorsten; Repp Reinald; Marschalek Rolf; Welte Karl; Haas Oskar A; Stanulla Martin
NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms.
Haematologica 2004;89(12):1492-7.
-
2004: Hasle H; Baumann I; Bergsträsser E; Fenu S; Fischer A; Kardos G; Kerndrup G; Locatelli F; Rogge T; Schultz K R; Starý J; Trebo M; van den Heuvel-Eibrink M M; Harbott J; Nöllke P; Niemeyer C M;
The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(12):2008-14.
-
2004: Meissner B; Stanulla M; Ludwig W-D; Harbott J; Möricke A; Welte K; Schrappe M
The GSTT1 deletion polymorphism is associated with initial response to glucocorticoids in childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(11):1920-3.
-
2004: Metzler Markus; Strissel Pamela L; Strick Reiner; Niemeyer Charlotte; Roettgers Silja; Borkhardt Arndt; Harbott Jochen; Ludwig Wolf D; Stanulla Martin; Schrappe Martin; Reinhardt Dirk; Creutzig Ursula; Beck Joern D; Rascher Wolfgang; Repp Reinald; Langer Thorsten
Emergence of translocation t(9;11)-positive leukemia during treatment of childhood acute lymphoblastic leukemia.
Genes, chromosomes & cancer 2004;41(3):291-6.
-
2004: Wilda Monika; Busch Kerstin; Klose Irmgard; Keller Thomas; Woessmann Wilhelm; Kreuder Joachim; Harbott Jochen; Borkhardt Arndt
Level of MYC overexpression in pediatric Burkitt's lymphoma is strongly dependent on genomic breakpoint location within the MYC locus.
Genes, chromosomes & cancer 2004;41(2):178-82.
-
2004: Busch Kerstin; Borkhardt Arndt; Wössmann Wilhelm; Reiter Alfred; Harbott Jochen
Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis.
Haematologica 2004;89(7):818-25.
-
2004: Tamm Ingo; Richter Stephan; Oltersdorf Doreen; Creutzig Ursula; Harbott Jochen; Scholz Frank; Karawajew Leonid; Ludwig Wolf-Dieter; Wuchter Christian
High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(11):3737-44.
-
2004: Heerema N A; Harbott J; Galimberti S; Camitta B M; Gaynon P S; Janka-Schaub G; Kamps W; Basso G; Pui C-H; Schrappe M; Auclerc M-F; Carroll A J; Conter V; Harrison C J; Pullen J; Raimondi S C; Richards S; Riehm H; Sather H N; Shuster J J; Silverman L B; Valsecchi M G; Aricò M;
Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(4):693-702.
-
2004: Ramakers-van Woerden N L; Beverloo H B; Veerman A J P; Camitta B M; Loonen A H; van Wering E R; Slater R M; Harbott J; den Boer M L; Ludwig W D; Haas O A; Janka-Schaub G E; Pieters R
In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(3):521-9.
-
2004: Peham Martina; Konrad Marianne; Harbott Jochen; König Margit; Haas Oskar A; Panzer-Grümayer E Renate
Clonal variation of the immunogenotype in relapsed ETV6/RUNX1-positive acute lymphoblastic leukemia indicates subclone formation during early stages of leukemia development.
Genes, chromosomes & cancer 2004;39(2):156-60.
-
2004: Fine Bernard M; Stanulla Martin; Schrappe Martin; Ho Minh; Viehmann Susanne; Harbott Jochen; Boxer Linda M
Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia.
Blood 2004;103(3):1043-9.
-
2004: Metzler M; Brehm U; Langer T; Viehmann S; Borkhardt A; Stanulla M; Schrappe M; Harbott J; Beck J D; Rascher W; Repp R
Asymmetric multiplex-polymerase chain reaction - a high throughput method for detection and sequencing genomic fusion sites in t(4;11).
British journal of haematology 2004;124(1):47-54.
-
2003: Tosi Sabrina; Hughes Jim; Scherer Stephen W; Nakabayashi Kazuhiko; Harbott Jochen; Haas Oskar A; Cazzaniga Giovanni; Biondi Andrea; Kempski Helena; Kearney Lyndal
Heterogeneity of the 7q36 breakpoints in the t(7;12) involving ETV6 in infant leukemia.
Genes, chromosomes & cancer 2003;38(2):191-200.
-
2003: Zwaan Christian M; Meshinchi Soheil; Radich Jerald P; Veerman Anjo J P; Huismans Dieuwke R; Munske Leonhard; Podleschny Martina; Hählen Karel; Pieters Rob; Zimmermann Martin; Reinhardt Dirk; Harbott Jochen; Creutzig Ursula; Kaspers Gertjan J L; Griesinger Frank
FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance.
Blood 2003;102(7):2387-94.
-
2003: Kardos Gabriela; Baumann Irith; Passmore S Jane; Locatelli Franco; Hasle Henrik; Schultz Kirk R; Starý Jan; Schmitt-Graeff Annette; Fischer Alexandra; Harbott Jochen; Chessells Judith M; Hann Ian; Fenu Susanna; Rajnoldi Angelo Cantú; Kerndrup Gitte; Van Wering Elisabeth; Rogge Tim; Nollke Peter; Niemeyer Charlotte M
Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7.
Blood 2003;102(6):1997-2003.
-
2003: Viehmann S; Teigler-Schlegel A; Bruch J; Langebrake C; Reinhardt D; Harbott J
Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(6):1130-6.
-
2003: Bruch Jochen; Wilda Monika; Teigler-Schlegel Andrea; Harbott Jochen; Borkhardt Arndt; Metzler Markus
Occurrence of an MLL/LAF4 fusion gene caused by the insertion ins(11;2)(q23;q11.2q11.2) in an infant with acute lymphoblastic leukemia.
Genes, chromosomes & cancer 2003;37(1):106-9.
-
2003: Langer Thorsten; Metzler Markus; Reinhardt Dirk; Viehmann Susanne; Borkhardt Arndt; Reichel Martin; Stanulla Martin; Schrappe Martin; Creutzig Ursula; Ritter Jörg; Leis Thomas; Jacobs Ulla; Harbott Jochen; Beck Jörn D; Rascher Wolfgang; Repp Reinald
Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides.
Genes, chromosomes & cancer 2003;36(4):393-401.
-
2003: Gamerdinger Ulrike; Teigler-Schlegel Andrea; Pils Sabine; Bruch Jochen; Viehmann Susanne; Keller Monika; Jauch Anna; Harbott Jochen
Cryptic chromosomal aberrations leading to an AML1/ETO rearrangement are frequently caused by small insertions.
Genes, chromosomes & cancer 2003;36(3):261-72.
-
2002: Zwaan Christian M; Kaspers Gertjan J L; Pieters Rob; Hählen Karel; Huismans Dieuwke R; Zimmermann Martin; Harbott Jochen; Slater Rosalyn M; Creutzig Ursala; Veerman Anjo J P
Cellular drug resistance in childhood acute myeloid leukemia is related to chromosomal abnormalities.
Blood 2002;100(9):3352-60.
-
2002: Borkhardt A; Wuchter C; Viehmann S; Pils S; Teigler-Schlegel A; Stanulla M; Zimmermann M; Ludwig W-D; Janka-Schaub G; Schrappe M; Harbott J
Infant acute lymphoblastic leukemia - combined cytogenetic, immunophenotypical and molecular analysis of 77 cases.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(9):1685-90.
-
2002: Hotfilder Marc; Röttgers Silja; Rosemann Annegret; Jürgens Heribert; Harbott Jochen; Vormoor Josef
Immature CD34+CD19- progenitor/stem cells in TEL/AML1-positive acute lymphoblastic leukemia are genetically and functionally normal.
Blood 2002;100(2):640-6.
-
2002: Ramakers-van Woerden N L; Pieters R; Hoelzer D; Slater R M; den Boer M L; Loonen A H; Harbott J; Janka-Schaub G E; Ludwig W-D; Ossenkoppele G J; van Wering E R; Veerman A J P;
In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: a report of the Dutch and German Leukemia Study Groups.
Medical and pediatric oncology 2002;38(6):379-86.
-
2002: Brown Jill; Jawad Mays; Twigg Stephen R F; Saracoglu Kaan; Sauerbrey Axel; Thomas Angela E; Eils Roland; Harbott Jochen; Kearney Lyndal
A cryptic t(5;11)(q35;p15.5) in 2 children with acute myeloid leukemia with apparently normal karyotypes, identified by a multiplex fluorescence in situ hybridization telomere assay.
Blood 2002;99(7):2526-31.
-
2001: Borkhardt A; Teigler-Schlegel A; Fuchs U; Keller C; König M; Harbott J; Haas O A
An ins(X;11)(q24;q23) fuses the MLL and the Septin 6/KIAA0128 gene in an infant with AML-M2.
Genes, chromosomes & cancer 2001;32(1):82-8.
-
2001: Fuchs U; Rehkamp G; Haas O A; Slany R; Konig M; Bojesen S; Bohle R M; Damm-Welk C; Ludwig W D; Harbott J; Borkhardt A
The human formin-binding protein 17 (FBP17) interacts with sorting nexin, SNX2, and is an MLL-fusion partner in acute myelogeneous leukemia.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(15):8756-61.
-
2001: Ferrari T; Weber B; Pils S; Harbott J; Borkhardt A
Absence of point mutations within the AML-1 gene in patients with MDS/AML and loss of chromosome 5q or 7.
Annals of hematology 2001;80(2):72-3.
-
2001: Seeger K; Viehmann S; Buchwald D; Harbott J; Schrappe M; Stary J; Henze G; Trka J
Treatment response and residual-disease monitoring in initial and relapsed TEL-AML1 positive childhood ALL.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(2):280-2.
-
2001: Wuchter C; Ratei R; Spahn G; Schoch C; Harbott J; Schnittger S; Haferlach T; Creutzig U; Sperling C; Karawajew L; Ludwig W D
Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping.
Haematologica 2001;86(2):154-61.
-
2001: Scholz I; Popp S; Granzow M; Schoell B; Holtgreve-Grez H; Takeuchi S; Schrappe M; Harbott J; Teigler-Schlegel A; Zimmermann M; Fischer C; Koeffler H P; Bartram C R; Jauch A
Comparative genomic hybridization in childhood acute lymphoblastic leukemia: correlation with interphase cytogenetics and loss of heterozygosity analysis.
Cancer genetics and cytogenetics 2001;124(2):89-97.
-
2000: Schrappe M; Reiter A; Zimmermann M; Harbott J; Ludwig W D; Henze G; Gadner H; Odenwald E; Riehm H
Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(12):2205-22.
-
2000: Tosi S; Harbott J; Teigler-Schlegel A; Haas O A; Pirc-Danoewinata H; Harrison C J; Biondi A; Cazzaniga G; Kempski H; Scherer S W; Kearney L
t(7;12)(q36;p13), a new recurrent translocation involving ETV6 in infant leukemia.
Genes, chromosomes & cancer 2000;29(4):325-32.
-
2000: Ramakers-van Woerden N L; Pieters R; Loonen A H; Hubeek I; van Drunen E; Beverloo H B; Slater R M; Harbott J; Seyfarth J; van Wering E R; Hählen K; Schmiegelow K; Janka-Schaub G E; Veerman A J
TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia.
Blood 2000;96(3):1094-9.
-
2000: Borkhardt A; Bojesen S; Haas O A; Fuchs U; Bartelheimer D; Loncarevic I F; Bohle R M; Harbott J; Repp R; Jaeger U; Viehmann S; Henn T; Korth P; Scharr D; Lampert F
The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(16):9168-73.
-
2000: Wuchter C; Karawajew L; Ruppert V; Schrappe M; Harbott J; Ratei R; Dörken B; Ludwig W D
Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia.
British journal of haematology 2000;110(1):154-60.
-
2000: Wuchter C; Harbott J; Schoch C; Schnittger S; Borkhardt A; Karawajew L; Ratei R; Ruppert V; Haferlach T; Creutzig U; Dörken B; Ludwig W D
Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(7):1232-8.
-
2000: Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig W D
Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
Haematologica 2000;85(7):711-21.
-
2000: Schrappe M; Reiter A; Ludwig W D; Harbott J; Zimmermann M; Hiddemann W; Niemeyer C; Henze G; Feldges A; Zintl F; Kornhuber B; Ritter J; Welte K; Gadner H; Riehm H
Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group.
Blood 2000;95(11):3310-22.
-
2000: Stanulla M; Kasper B; Schrappe M; Viehmann S; Harbott J; Ludwig W D; Welte K
Granulocyte colony-stimulating factor receptor expression and 11q23/MLL genotype in childhood acute lymphoblastic leukemia developing during the first 18 months of life.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(2):337-8.
-
2000: Bernstein J; Dastugue N; Haas O A; Harbott J; Heerema N A; Huret J L; Landman-Parker J; LeBeau M M; Leonard C; Mann G; Pages M P; Perot C; Pirc-Danoewinata H; Roitzheim B; Rubin C M; Slociak M; Viguie F
Nineteen cases of the t(1;22)(p13;q13) acute megakaryblastic leukaemia of infants/children and a review of 39 cases: report from a t(1;22) study group.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(1):216-8.
-
1999: Gillert E; Leis T; Repp R; Reichel M; Hösch A; Breitenlohner I; Angermüller S; Borkhardt A; Harbott J; Lampert F; Griesinger F; Greil J; Fey G H; Marschalek R
A DNA damage repair mechanism is involved in the origin of chromosomal translocations t(4;11) in primary leukemic cells.
Oncogene 1999;18(33):4663-71.
-
1999: Jaju R J; Haas O A; Neat M; Harbott J; Saha V; Boultwood J; Brown J M; Pirc-Danoewinata H; Krings B W; Müller U; Morris S W; Wainscoat J S; Kearney L
A new recurrent translocation, t(5;11)(q35;p15.5), associated with del(5q) in childhood acute myeloid leukemia. The UK Cancer Cytogenetics Group (UKCCG)
Blood 1999;94(2):773-80.
-
1999: Viehmann S; Borkhardt A; Lampert F; Harbott J
Multiplex PCR--a rapid screening method for detection of gene rearrangements in childhood acute lymphoblastic leukemia.
Annals of hematology 1999;78(4):157-62.
-
1999: Loncarevic I F; Roitzheim B; Ritterbach J; Viehmann S; Borkhardt A; Lampert F; Harbott J
Trisomy 21 is a recurrent secondary aberration in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusion.
Genes, chromosomes & cancer 1999;24(3):272-7.
-
1999: Hasle H; Aricò M; Basso G; Biondi A; Cantù Rajnoldi A; Creutzig U; Fenu S; Fonatsch C; Haas O A; Harbott J; Kardos G; Kerndrup G; Mann G; Niemeyer C M; Ptoszkova H; Ritter J; Slater R; Starý J; Stollmann-Gibbels B; Testi A M; van Wering E R; Zimmermann M
Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. European Working Group on MDS in Childhood (EWOG-MDS).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(3):376-85.
-
1998: Schrappe M; Aricò M; Harbott J; Biondi A; Zimmermann M; Conter V; Reiter A; Valsecchi M G; Gadner H; Basso G; Bartram C R; Lampert F; Riehm H; Masera G
Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome.
Blood 1998;92(8):2730-41.
-
1998: Ratei R; Sperling C; Karawajew L; Schott G; Schrappe M; Harbott J; Riehm H; Ludwig W D
Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia.
Annals of hematology 1998;77(3):107-14.
-
1998: Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
Klinische Pädiatrie 1998;210(4):173-9.
-
1998: Leis T; Repp R; Borkhardt A; Metzler M; Schläger F; Harbott J; Lampert F
A new fingerprint method for sequence analysis of chromosomal translocations at the genomic DNA level.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12(5):758-63.
-
1998: Dördelmann M; Schrappe M; Reiter A; Zimmermann M; Graf N; Schott G; Lampert F; Harbott J; Niemeyer C; Ritter J; Dörffel W; Nessler G; Kühl J; Riehm H
Down's syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials. Berlin-Frankfurt-Münster Group.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12(5):645-51.
-
1998: Ritterbach J; Hiddemann W; Beck J D; Schrappe M; Janka-Schaub G; Ludwig W D; Harbott J; Lampert F
Detection of hyperdiploid karyotypes (>50 chromosomes) in childhood acute lymphoblastic leukemia (ALL) using fluorescence in situ hybridization (FISH).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12(3):427-33.
-
1998: Tosi S; Giudici G; Mosna G; Harbott J; Specchia G; Grosveld G; Privitera E; Kearney L; Biondi A; Cazzaniga G
Identification of new partner chromosomes involved in fusions with the ETV6 (TEL) gene in hematologic malignancies.
Genes, chromosomes & cancer 1998;21(3):223-9.
-
1997: Harbott J; Viehmann S; Borkhardt A; Henze G; Lampert F
Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse.
Blood 1997;90(12):4933-7.
-
1997: Borkhardt A; Cazzaniga G; Viehmann S; Valsecchi M G; Ludwig W D; Burci L; Mangioni S; Schrappe M; Riehm H; Lampert F; Basso G; Masera G; Harbott J; Biondi A
Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Study Group.
Blood 1997;90(2):571-7.
-
1997: Niemeyer C M; Arico M; Basso G; Biondi A; Cantu Rajnoldi A; Creutzig U; Haas O; Harbott J; Hasle H; Kerndrup G; Locatelli F; Mann G; Stollmann-Gibbels B; van't Veer-Korthof E T; van Wering E; Zimmermann M
Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)
Blood 1997;89(10):3534-43.
-
1997: Borkhardt A; Repp R; Haas O A; Leis T; Harbott J; Kreuder J; Hammermann J; Henn T; Lampert F
Cloning and characterization of AFX, the gene that fuses to MLL in acute leukemias with a t(X;11)(q13;q23).
Oncogene 1997;14(2):195-202.
-
1996: Creutzig U; Ritter J; Vormoor J; Ludwig W D; Niemeyer C; Reinisch I; Stollmann-Gibbels B; Zimmermann M; Harbott J
Myelodysplasia and acute myelogenous leukemia in Down's syndrome. A report of 40 children of the AML-BFM Study Group.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(11):1677-86.
-
1996: Schlieben S; Borkhardt A; Reinisch I; Ritterbach J; Janssen J W; Ratei R; Schrappe M; Repp R; Zimmermann M; Kabisch H; Janka-Schaub G; Bartram C R; Ludwig W D; Riehm H; Lampert F; Harbott J
Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(6):957-63.
-
1996: Tosi S; Harbott J; Haas O A; Douglas A; Hughes D M; Ross F M; Biondi A; Scherer S W; Kearney L
Classification of deletions and identification of cryptic translocations involving 7q by fluorescence in situ hybridization (FISH).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(4):644-9.
-
1995: Creutzig U; Harbott J; Sperling C; Ritter J; Zimmermann M; Löffler H; Riehm H; Schellong G; Ludwig W D
Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87.
Blood 1995;86(8):3097-108.
-
1995: Borkhardt A; Brettreich S; Borkhardt A K; Repp R; Harbott J; Kreuder J; Lampert F
Low frequency of RAS gene mutations and absence of mutations within the FLR exon of NF1 in patients with therapy-related leukemias.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(10):1790-1.
-
1995: Creutzig U; Ritter J; Ludwig W D; Niemeyer C; Reinisch I; Stollmann-Gibbels B; Zimmermann M; Harbott J
[Acute myeloid leukemia in children with Down syndrome]
Klinische Pädiatrie 1995;207(4):136-44.
-
1995: Sperling C; Büchner T; Creutzig U; Ritter J; Harbott J; Fonatsch C; Sauerland C; Mielcarek M; Maschmeyer G; Löffler H
Clinical, morphologic, cytogenetic and prognostic implications of CD34 expression in childhood and adult de novo AML.
Leukemia & lymphoma 1995;17(5-6):417-26.
-
1995: Seyger M M; Ritterbach J; Creutzig U; Gnekow A K; Göbel U; Graf N; Reiter A; Lampert F; Harbott J
12q13, a new recurrent breakpoint in acute non-lymphoblastic leukemia.
Cancer genetics and cytogenetics 1995;80(1):23-8.
-
1995: Nishida K; Ritterbach J; Repp R; Harbott J; Lampert F
Characterization of chromosome 8 abnormalities by fluorescence in situ hybridization in childhood B-acute lymphoblastic leukemia/non-Hodgkin lymphoma.
Cancer genetics and cytogenetics 1995;79(1):8-14.
-
1995: Repp R; Borkhardt A; Haupt E; Kreuder J; Brettreich S; Hammermann J; Nishida K; Harbott J; Lampert F
Detection of four different 11q23 chromosomal abnormalities by multiplex-PCR and fluorescence-based automatic DNA-fragment analysis.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(1):210-5.
-
1994: Janssen J W; Ludwig W D; Borkhardt A; Spadinger U; Rieder H; Fonatsch C; Hossfeld D K; Harbott J; Schulz A S; Repp R
Pre-pre-B acute lymphoblastic leukemia: high frequency of alternatively spliced ALL1-AF4 transcripts and absence of minimal residual disease during complete remission.
Blood 1994;84(11):3835-42.
-
1994: Tosi S; Ritterbach J; Maglia O; Harbott J; Riehm H; Masera G; Biondi A; Lampert F
Double target in situ hybridization applied to the study of numerical aberrations in childhood acute lymphoblastic leukemia.
Cancer genetics and cytogenetics 1994;73(2):103-8.
-
1994: Griesinger F; Elfers H; Ludwig W D; Falk M; Rieder H; Harbott J; Lampert F; Heinze B; Hoelzer D; Thiel E
Detection of HRX-FEL fusion transcripts in pre-pre-B-ALL with and without cytogenetic demonstration of t(4;11).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(4):542-8.
-
1993: Izraeli S; Henn T; Strobl H; Ludwig W D; Kovar H; Haas O A; Harbott J; Bartram C R; Gadner H; Lion T
Expression of identical E2A/PBX1 fusion transcripts occurs in both pre-B and early pre-B immunological subtypes of childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(12):2054-6.
-
1993: Li L; Ritterbach J; Harbott J; Schroyens W; Lohmeyer J; Pralle H; Lampert F
Blastic phase chronic myeloid leukemia with a four-break rearrangement: t(11;9)(9;22)(q23;p22q34;q11).
Cancer genetics and cytogenetics 1993;68(2):131-4.
-
1993: Borkhardt A; Repp R; Harbott J; Lakomek M; Janssen J W; Schlieben S; Bartram C R; Lampert F
BCR-ABL rearrangement in a child with acute myelogenous leukaemia without a Philadelphia chromosome.
British journal of haematology 1993;84(2):341-2.
-
1993: Izraeli S; Janssen J W; Haas O A; Harbott J; Brok-Simoni F; Walther J U; Kovar H; Henn T; Ludwig W D; Reiter A
Detection and clinical relevance of genetic abnormalities in pediatric acute lymphoblastic leukemia: a comparison between cytogenetic and polymerase chain reaction analyses.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(5):671-8.
-
1993: Borkhardt A; Repp R; Harbott J; Kreuder J; Lampert F
Quantification of leukaemic cells based on heteroduplex formation of tal-1 gene sequences after PCR coamplification.
British journal of haematology 1993;83(1):39-44.
-
1993: Ludwig W D; Harbott J; Bartram C R; Komischke B; Sperling C; Teichmann J V; Seibt-Jung H; Notter M; Odenwald E; Nehmer A
Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: experience of the BFM study 86.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;131():269-82.
-
1993: Harbott J; Ritterbach J; Ludwig W D; Bartram C R; Reiter A; Lampert F
Clinical significance of cytogenetic studies in childhood acute lymphoblastic leukemia: experience of the BFM trials.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;131():123-32.
-
1993: Hiddemann W; Harbott J; Ludwig W D; Ritter J; Nehmer A; Reiter A; Kolkmeyer A; Laing T; Riehm H
DNA aneuploidy in childhood acute lymphoblastic leukemia: relation to clinical determinants and prognosis within four consecutive BFM trials.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;131():113-21.
-
1992: Reiter A; Schrappe M; Ludwig W D; Lampert F; Harbott J; Henze G; Niemeyer C M; Gadner H; Müller-Weihrich S; Ritter J
Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group.
Blood 1992;80(10):2471-8.
-
1992: Vormoor J; Ritter J; Creutzig U; Boos J; Heyen P; Ludwig W D; Harbott J; Löffler H; Schellong G
Acute myelogenous leukaemia in children under 2 years--experiences of the West German AML studies BFM-78, -83 and -87. AML-BFM Study Group.
The British journal of cancer. Supplement 1992;18():S63-7.
-
1992: Lampert F; Harbott J; Ritterbach J
Cytogenetic findings in acute leukaemias of infants.
The British journal of cancer. Supplement 1992;18():S20-2.
-
1992: Borkhardt A; Repp R; Harbott J; Keller C; Berner F; Ritterbach J; Lampert F
Frequency and DNA sequence of tal-1 rearrangement in children with T-cell acute lymphoblastic leukemia.
Annals of hematology 1992;64(6):305-8.
-
1992: Lion T; Haas O A; Harbott J; Bannier E; Ritterbach J; Jankovic M; Fink F M; Stojimirovic A; Herrmann J; Riehm H J
The translocation t(1;22)(p13;q13) is a nonrandom marker specifically associated with acute megakaryocytic leukemia in young children.
Blood 1992;79(12):3325-30.
-
1991: Lampert F; Harbott J; Ritterbach J; Schellong G; Ritter J; Creutzig U; Riehm H; Reiter A
Karyotypes in acute childhood leukemias may lose prognostic significance with more intensive and specific chemotherapy.
Cancer genetics and cytogenetics 1991;54(2):277-9.
-
1991: Lampert F; Harbott J; Ritterbach J
[Chromosome aberrations in acute leukemia in childhood: analysis of 1009 patients]
Klinische Pädiatrie 1991;203(4):311-8.
-
1991: Maurer J; Janssen J W; Thiel E; van Denderen J; Ludwig W D; Aydemir U; Heinze B; Fonatsch C; Harbott J; Reiter A
Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction.
Lancet 1991;337(8749):1055-8.
-
1990: Ludwig W D; Thiel E; Köller U; Bartram C R; Harbott J; Teichmann J V; Seibt-Jung H; Creutzig U; Ritter J; Riehm H
Incidence and clinical implications of acute hybrid leukemia in childhood.
Haematology and blood transfusion 1990;33():516-22.
-
1990: Creutzig U; Niederbiermann G; Ritter J; Harbott J; Löffler H; Schellong G
Prognostic significance of eosinophilia in acute myelomonocytic leukemia in relation to induction treatment.
Haematology and blood transfusion 1990;33():226-32.
-
1990: Ritterbach J; Harbott J; Ritter J; Lampert F
Chromosomal aberrations in childhood acute nonlymphoblastic leukemia.
Haematology and blood transfusion 1990;33():153-6.
-
1990: Harbott J; Ritterbach J; Janka-Schaub G; Ludwig W D; Reiter A; Riehm H; Lampert F
Cytogenetics of childhood acute lymphoblastic leukemia in multicenter trials.
Haematology and blood transfusion 1990;33():451-8.
-
1989: Köller U; Haas O A; Ludwig W D; Bartram C R; Harbott J; Panzer-Grümayer R; Hansen-Hagge T; Ritter J; Creutzig U; Knapp W
Phenotypic and genotypic heterogeneity in infant acute leukemia. II. Acute nonlymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1989;3(10):708-14.
-
1989: Ludwig W D; Bartram C R; Harbott J; Köller U; Haas O A; Hansen-Hagge T; Heil G; Seibt-Jung H; Teichmann J V; Ritter J
Phenotypic and genotypic heterogeneity in infant acute leukemia. I. Acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1989;3(6):431-9.
-
1989: Bartram C R; Ludwig W D; Hiddemann W; Lyons J; Buschle M; Ritter J; Harbott J; Fröhlich A; Janssen J W
Acute myeloid leukemia: analysis of ras gene mutations and clonality defined by polymorphic X-linked loci.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1989;3(4):247-56.
-
1989: Harbott J; Ritterbach J; Lampert F
Leukemia cytogenetics in children: results of the German therapy studies.
Haematology and blood transfusion 1989;32():121-6.
-
1988: Ludwig W D; Bartram C R; Ritter J; Raghavachar A; Hiddemann W; Heil G; Harbott J; Seibt-Jung H; Teichmann J V; Riehm H
Ambiguous phenotypes and genotypes in 16 children with acute leukemia as characterized by multiparameter analysis.
Blood 1988;71(6):1518-28.
-
1988: Lampert F; Harbott J; Ritterbach J; Ludwig W D; Fonatsch C; Schwamborn D; Stier B; Gnekow A; Gerein V; Stollmann B
T-cell acute childhood lymphoblastic leukemia with chromosome 14 q 11 anomaly: a morphologic, immunologic, and cytogenetic analysis of 10 patients.
Blut 1988;56(3):117-23.
-
1988: Rudolph B; Harbott J; Lampert F
Fragile sites and neuroblastoma: fragile site at 1p13.1 and other points on lymphocyte chromosomes from patients and family members.
Cancer genetics and cytogenetics 1988;31(1):83-94.
-
1987: Lampert F; Harbott J; Ludwig W D; Bartram C R; Ritter J; Gerein V; Neidhardt M; Mertens R; Graf N; Riehm H
Acute leukemia with chromosome translocation (4;11): 7 new patients and analysis of 71 cases.
Blut 1987;54(6):325-35.
-
1986: Harbott J; Engel R; Gerein V; Schwamborn D; Rudolph R; Lampert F
(11; 14) translocation in three boys with acute lymphoblastic leukemia of T-cell immunophenotype.
Blut 1986;52(1):45-50.
Sign-in to see more